In briefBMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7204.210b (Published 24 July 1999) Cite this as: BMJ 1999;319:210
UK agrees new drug pricing scheme: The United Kingdom last week agreed new terms for the Pharmaceutical Price Regulation Scheme—a voluntary system setting out the profit that manufacturers can earn on the sale of brand name products to the NHS. The terms of the scheme agreed a price reduction of 4.5% on branded medicines and a ban on price …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial